- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00671463
Pancreatic Stent to Prevent Leak After Distal Pancreatectomy (LEAPS)
June 10, 2013 updated by: William R. Brugge, MD, Massachusetts General Hospital
Leak Elimination After Pancreatic Stenting, a Randomized Controlled Trial
The purpose of this study is to investigate an intervention to prevent complications after pancreas surgery.
The goal is to determine if placing a stent into the pancreatic duct before surgery will decrease or prevent leaking from the pancreatic duct after surgery.
Leaks are common after pancreas surgery and can result in serious problems and post-operative pain.
The study will compare two groups.
One group will have the stent before surgery, and the other group will have standard pancreas surgery, no endoscopy, and no stent.
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02114
- Massachusetts General Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Adult patients (greater than or equal to 18 years of age)
- Scheduled to undergo an elective laparoscopic or open distal pancreatectomy
- Willing to undergo pre-operative endoscopy
- Consenting to the procedure
Exclusion Criteria:
- Contraindication to abdominal surgery
- Contraindication to general anesthesia or distal pancreatectomy
- Contraindication to upper endoscopy or ERCP
- Prior history of gastric bypass or other abdominal surgery in whom the ampulla will not be accessible via routine ERCP
- Ongoing pancreatitis
- Pancreatic necrosis or abscess
- History of sphincter of Oddi dysfunction
- History of ERCP-induced pancreatitis
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 1
Pre-operative pancreatic duct stenting
|
In the treatment arm, patients will have a pancreatic duct stent placed prior to having their distal pancreatectomy.
|
No Intervention: 2
Control group, no endoscopy and no stent pre-operatively
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Pancreatic leak
Time Frame: Post-operative day 3
|
Post-operative day 3
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Peritoneal fluid analysis
Time Frame: Daily
|
Daily
|
Serum biochemical analysis
Time Frame: Daily
|
Daily
|
Clinical outcomes
Time Frame: Daily
|
Daily
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Director: Field F Willingham, MD, MPH, MGH
- Study Director: Denise W Gee, MD, MGH
- Study Director: Sevdenur Cizginer, MD, MGH
- Principal Investigator: David W Rattner, MD, MGH
- Principal Investigator: William R Brugge, MD, MGH
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2008
Primary Completion (Anticipated)
April 1, 2010
Study Registration Dates
First Submitted
May 1, 2008
First Submitted That Met QC Criteria
May 2, 2008
First Posted (Estimate)
May 5, 2008
Study Record Updates
Last Update Posted (Estimate)
June 11, 2013
Last Update Submitted That Met QC Criteria
June 10, 2013
Last Verified
June 1, 2013
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2007P000965
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pancreatic Cancer
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CelgeneWithdrawnPancreatic Ductal Adenocarcinoma | Stage III Pancreatic Cancer | Stage IV Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic CancerUnited States
-
University of NebraskaNational Cancer Institute (NCI)CompletedPancreatic Adenocarcinoma | Stage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage II Pancreatic Cancer | Stage I Pancreatic Cancer | Resectable Pancreatic Carcinoma | Stage IA Pancreatic Cancer | Stage IB Pancreatic CancerUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)TerminatedPancreatic Adenocarcinoma | Resectable Pancreatic Cancer | Stage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic Cancer | Poorly Differentiated Malignant Neoplasm | Undifferentiated Pancreatic CarcinomaUnited States
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI)CompletedPancreatic Adenocarcinoma | Recurrent Pancreatic Carcinoma | Stage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic CancerUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)WithdrawnStage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic Cancer
-
National Cancer Institute (NCI)CompletedStage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic CancerUnited States
-
University of UtahNovartis PharmaceuticalsRecruitingMetastatic Pancreatic Carcinoma | Unresectable Pancreatic Carcinoma | Stage III Pancreatic Cancer | Stage IV Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage II Pancreatic CancerUnited States
-
University of Wisconsin, MadisonCompletedStage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic CancerUnited States
-
Fudan UniversityUnknownStage ⅠA Pancreatic Cancer | Stage ⅠB Pancreatic Cancer | Stage ⅡA Pancreatic Cancer | Stage ⅡB Pancreatic CancerChina
-
Shanghai Zhongshan HospitalFudan UniversityNot yet recruitingPancreatic Cancer Stage III | Pancreatic Cancer, Stage IB | Pancreatic Cancer, Stage IIA | Pancreatic Cancer, Stage IIBChina
Clinical Trials on Pancreatic duct stenting
-
University Hospital Schleswig-HolsteinWithdrawnChronic Acute PancreatitisGermany
-
Instituto Ecuatoriano de Enfermedades DigestivasActive, not recruitingBiliary Tract DiseasesEcuador
-
Second Affiliated Hospital, School of Medicine,...Ningbo No. 1 Hospital; Huizhou Municipal Central Hospital; Taizhou Hospital of... and other collaboratorsRecruiting
-
Air Force Military Medical University, ChinaCompleted
-
AdventHealthCompletedWalled Off Necrosis | Necrotizing PancreatitisUnited States
-
Changhai HospitalEnrolling by invitationChronic PancreatitisChina
-
Seoul National University HospitalCompletedPancreatic FistulaKorea, Republic of
-
Washington University School of MedicineNorthwestern University; University of OklahomaCompletedEndoscopic Retrograde Cholangiopancreatography (ERCP) | Bile Duct CannulationUnited States
-
Shanghai Zhongshan HospitalRenJi Hospital; First Affiliated Hospital Xi'an Jiaotong University; The Affiliated... and other collaboratorsNot yet recruiting
-
Tampere UniversityWithdrawn